HCV Protease

Inhibitory Selectivity
Catalog No.Inhibitor Name HCV Protease
A10159Daclatasvir (BMS-790052)
****
A10902Telaprevir (VX-950)
**
A10980Lomibuvir (VX-222, VCH-222)
*
A10284Danoprevir (ITMN-191)
***
A13155Ledipasvir (GS5885)
A11294Anguizole
**
A11295Asunaprevir (BMS-650032)
****
A11332Boceprevir (SCH-503034)
***
A11343Ciluprevir (BILN 2061)
***
A11580Simeprevir
****

Notes:
1.Hover mouse over " * " to view the IC50 value.(A few compounds have proven potency but without published IC50 data.)
2.For more details about the compound, click on the product name of your interest.
3.The higher the number of " * " is, the more potent the inhibitor or activator is.
4."" refers to compounds which do inhibitory effects on the related isoform, but without specific value.



33 Item(s)

per page

Set Descending Direction
Catalog No. Product Name Application Product Information
A10159 SALE

BMS-790052

HCV NS5A inhibitor
BMS-790052 is an NS5A inhibitor under investigation for the treatment of hepatitis C virus (HCV) infection.
A11529 SALE

PSI-7977

HCV Nucleotide Inhibitor
PSI-7977 is a phosphoramidate prodrug of PSI-7851, a nucleoside analog that, when phosphorylated, inhibits the RNA-dependent RNA polymerase of hepatitis C virus (EC50 = 92 nM).
A11530 SALE

PSI-6206

HCV RNA polymerase inhibitor
PSI-6206 is the deaminated derivative of PSI-6130, which is a potent inhibitor of hepatitis C virus (HCV) replication in the subgenomic HCV reolicon system.
A14106

Faldaprevir

HCV Protease Inhibitor
Faldaprevir is a hepatitis C virus protease inhibitor.
A13965

MK 8742 (elbasvir)

HCV NS5A inhibitor
MK 8742, also known as Elbasvir, is a HCV NS5A inhibitor, which is an all-oral, interferon-free regimen for the treatment of HCV infection.
A14046

GS-9451

HCV NS3/4A protease inhibitor
GS-9451, a novel hepatitis C virus (HCV) nonstructural 3/4a (NS3/4a) protease inhibitor, is highly active in patients infected with HCV genotype 1 (GT 1).
A15166

MK-5172 hydrate

HCV inhibitor
MK-5172 is a novel P2-P4 quinoxaline macrocyclic HCV NS3/4a protease inhibitor currently in clinical development.
A15167

MK-5172 potassium salt

HCV inhibitor
MK-5172 is a novel P2-P4 quinoxaline macrocyclic HCV NS3/4a protease inhibitor currently in clinical development.
A15168

MK-5172 sodium salt

HCV inhibitor
MK-5172 is a novel P2-P4 quinoxaline macrocyclic HCV NS3/4a protease inhibitor currently in clinical development.
A15224

RO-9187

HCV replication inhibitor
RO-9187 is a potent inhibitor of HCV virus replication in the replicon system (IC(50) = 171 +/- 12 nM; CC(50) >1 mM).
A15479

VCH-759

HCV Polymerase Inhibitor
VCH-759 is a non-nucleoside inhibitor of HCV RNA-dependent polymerase with sub-micromolar IC50 values versus genotype 1a/1b replicons.
A11510

Nesbuvir

HCV Inhibitor
HCV-796 is a selectively inhibitor of hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase.
A11580

Simeprevir

HCV NS3/4A protease inhibitor
Simeprevir is a potent inhibitor of HCV NS3/4A protease (Ki = 0.36 nM) and viral replication (replicon EC50 = 7.8 nM).
A11600

Vaniprevir

HCV NS3/4A protease inhibitor
Vaniprevir is a non-covalent competitive inhibitor of the hepatitis C virus (HCV) NS3/4A protease.
A13155 SALE

Ledipasvir (GS 5885)

NS5A inhibitor
Ledipasvir is an inhibitor of the hepatitis C virus HCV NS5A protein
A13118

Celgosivir

alpha-glucosidase I inhibitor
Celgosivir is an alpha-glucosidase I inhibitor for the potential treatment of HCV infection.
A10284 SALE

Danoprevir (RG7227)

HCV NS3/4A protease inhibitor
Danoprevir is a potent inhibitor of the HCV NS3/4A serine protease.
A10980

VX-222

HCV Protease inhibitor
VX-222 is a small molecule non-nucleoside inhibitor of HCV NS5B polymerase that is being investigated for the treatment of hepatitis C virus infection.
A10902 SALE

Telaprevir (VX-950)

HCV NS3-4A protease inhibitor
Telaprevir (VX-950) is known as protease inhibitors that inhibits the hepatitis C virus NS3.4A serine protease.
A11294

Anguizole

HCV replication Inhibitor
Anguizole is a small molecule inhibits HCV replication and alters NS4B's subcellular distribution.
A11295 SALE

Asunaprevir (BMS-650032)

NS3 protease inhibitor
Asunaprevir is an inhibitor of the viral enzyme serine protease NS3.
A11332 SALE

Boceprevir (SCH-503034)

HCV Protease Inhibitor
Boceprevir is a protease inhibitor used as a treatment for hepatitis C genotype 1.
A11335

Balapiravir (R1626)

Polymerase inhibitor
Balapiravir (R1626, RG1626) is the prodrug of a nucleoside analogue inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase (R1479, RG1479).
A11336

BMS-790052 2HCl

NS5A inhibitor
BMS-790052 is an NS5A inhibitor under investigation for the treatment of hepatitis C virus (HCV) infection.
A13105

Setrobuvir (ANA-598)

HCV Polymerase Inhibitor
Setrobuvir (ANA-598) is a direct-acting antiviral or DAA, is a non-nucleoside inhibitor of the HCV RNA polymerase
A12374

VCH-916

HCV NS5B polymerase inhibitor
VCH-916 is a novel nonnucleoside HCV NS5B polymerase inhibitor.
A11583

Tegobuvir (GS-9190)

NS5B polymerase inhibitor
Tegobuvir (GS-9190 is a non-nucleoside NS5B polymerase inhibitor.
A11519 SALE

PSI-6130

HCV Nucleoside Inhibitor
PSI-6130(R 1656) is a Hepatitis C Virus Nucleoside Inhibitor.
A11343 SALE

Ciluprevir (BILN 2061)

HCV NS3 protease Inhibitor
Ciluprevir is a specific and potent peptidomimetic inhibitor of the HCV NS3 protease.
A13787

MK-5172

HCV NS3/4a inhibitor
MK-5172 is a selective inhibitor of Hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants.
A13526

GS-9256

HCV NS3 inhibitor
GS-9451 is a potent macrocyclic HCV NS3 PI that achieved a median maximal change in HCV RNA of 3.6 log10 IU/mL (range, -4.7 log10 to -3.1 log10 IU/mL) following 3-day monotherapy in treatment-nave patients with HCV genotype 1 infection during phase I.
A13414

BI207127 (Deleobuvir)

HCV NS5B polymerase inhibitor
BI 207127 was a non-nucleoside hepatitis C virus NS5B polymerase inhibitor for the treatment of hepatitis C
A11506

Narlaprevir

NS3 protease inhibitor
Narlaprevir is a potent, selective, orally bioavailable NS3 protease inhibitor(Ki=6 nM; EC90=40 nM)

33 Item(s)

per page

Set Descending Direction